Literature DB >> 1624258

In vitro study of rat prostate 5 alpha-reductase activity and its inhibition.

I Faredin1, I Tóth, J Oszlánczy, S Scultéty.   

Abstract

A simple and rapid method of measuring 5 alpha-reductase (5 alpha-R) activity and of determining the kinetic parameters (KM and Vmax) of the enzyme is described. The 5 alpha-R activity in the homogenate of the prostate of Wistar rats aged 8-12 weeks was established, and the effects of natural and synthetic steroids and of non-steroidal antiandrogens (IC50) upon the 5 alpha-R activity were studied. Of the natural steroids, 17-OH-progesterone was found to have the highest inhibitory effect (IC50 = 1.35 microM), followed in decreasing order by progesterone (IC50 = 5.0 microM) and 4-androstene-3,17-dione (IC50 = 21.6 microM). Oestradiol-17 beta had practically no inhibitory effect. Of the synthetic steroids, 4-MA had the highest inhibitory effect (IC50 = 0.068 microM), followed by nortestosterone (IC50 = 7.4 microM) and RU-486 (Mifepristone) (IC50 = 115 microM). Even at 1000 microM, cyproterone acetate exerted no inhibitory effect. Of the nonsteroidal compounds, ketoconazole proved a weak inhibitor (IC50 = 115 microM), while flutamide was practically ineffective.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624258     DOI: 10.1007/bf02549642

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  17 in total

1.  The effect of ketoconazole on fertility of male rats.

Authors:  D P Waller; A Martin; B H Vickery; L J Zaneveld
Journal:  Contraception       Date:  1990-04       Impact factor: 3.375

2.  Testosterone metabolism in prostate; formation of androstan-17-beta-ol-3-one and androst-4-ene-3, 17-dione, and inhibitory effect of natural and synthetic estrogens.

Authors:  J Shimazaki; H Kurihara; Y Ito; K Shida
Journal:  Gunma J Med Sci       Date:  1965-12

3.  The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro.

Authors:  N Bruchovsky; J D Wilson
Journal:  J Biol Chem       Date:  1968-04-25       Impact factor: 5.157

4.  Virilization of the Wolffian duct in the rat fetus by various androgens.

Authors:  F M Schultz; J D Wilson
Journal:  Endocrinology       Date:  1974-04       Impact factor: 4.736

5.  The intranuclear binding of testosterone and 5-alpha-androstan-17-beta-ol-3-one by rat prostate.

Authors:  N Bruchovsky; J D Wilson
Journal:  J Biol Chem       Date:  1968-11-25       Impact factor: 5.157

6.  Species differences in prostatic steroid 5 alpha-reductases of rat, dog, and human.

Authors:  T Liang; M A Cascieri; A H Cheung; G F Reynolds; G H Rasmusson
Journal:  Endocrinology       Date:  1985-08       Impact factor: 4.736

7.  Pharmacological induction of 5 alpha-reductase deficiency in the rat: separation of testosterone-mediated and 5 alpha-dihydrotestosterone-mediated effects.

Authors:  T R Blohm; M E Laughlin; H D Benson; J O Johnston; C L Wright; G L Schatzman; P M Weintraub
Journal:  Endocrinology       Date:  1986-09       Impact factor: 4.736

8.  Retardation of prostate tumor progression in the Noble rat by 4-methyl-4-aza-steroidal inhibitors of 5 alpha-reductase.

Authors:  N Kadohama; M Wakisaka; U Kim; J P Karr; G P Murphy; A A Sandberg
Journal:  J Natl Cancer Inst       Date:  1985-02       Impact factor: 13.506

Review 9.  The pathogenesis of benign prostatic hyperplasia.

Authors:  J D Wilson
Journal:  Am J Med       Date:  1980-05       Impact factor: 4.965

10.  The development of a male pseudohermaphroditic rat using an inhibitor of the enzyme 5 alpha-reductase.

Authors:  J Imperato-McGinley; Z Binienda; A Arthur; D T Mininberg; E D Vaughan; F W Quimby
Journal:  Endocrinology       Date:  1985-02       Impact factor: 4.736

View more
  2 in total

1.  In vitro inhibition of testicular delta 5-3 beta-hydroxysteroid dehydrogenase and prostatic 5 alpha-reductase activities in rats and humans by strogen forte extract.

Authors:  I Tóth; M Szécsi; J Julesz; I Faredin; B Behnke
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

Review 2.  Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancer.

Authors:  L B Barradell; D Faulds
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.